AI

BioEVAL: A global, multi-institutional benchmark of large language and multimodal models for bioengineering

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 28/09/2026, 04:03:24 UTC.

Briefings

BioEVAL is a global multi-institutional benchmark launched in September 2026 to assess experimental reasoning in bioengineering using 608 items across 11 subfields. It includes 359 MCQs, 218 literature synthesis tasks, and 10 multimodal problems. Evaluation involved expert review and a blinded consensus audit that removed 21 questions, leaving 359 retained MCQs for scoring. Models ranging from cloud-scale to consumer-grade GPUs were tested, achieving up to 90% MCQ accuracy and 80% on multimodal tasks, with performance varying significantly by subfield.

Key points

• BioEVAL launched in September 2026 as a global initiative to evaluate experimental reasoning in bioengineering using 608 items across 11 subfields.
• The benchmark includes 359 MCQs, 218 literature synthesis tasks, and 10 multimodal problems, with 21 questions removed via a blinded consensus audit.

Context and limitations

The benchmark covers 11 bioengineering subfields plus uncategorized items; evaluation relies on expert review and centralized quality control, and results are based on retained items after audit.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/09/2026, 04:04:44 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibaxgcj4oabju5k5hc4jnawj7puosnuglkqxikif2zzf7de6nxmk4